Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
Abstract Background MYC is a heterogeneously expressed transcription factor that plays a multifunctional role in many biological processes such as cell proliferation and differentiation. It is also associated with many types of cancer including the malignant lymphomas. There are two types of aggress...
Main Authors: | Karsten Kleo, Lora Dimitrova, Elisabeth Oker, Nancy Tomaszewski, Erika Berg, Franziska Taruttis, Julia C. Engelmann, Philipp Schwarzfischer, Jörg Reinders, Rainer Spang, Wolfram Gronwald, Peter J. Oefner, Michael Hummel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5537-0 |
Similar Items
-
To Detach, Migrate, Adhere, and Metastasize: CD97/<i>ADGRE5</i> in Cancer
by: Gabriela Aust, et al.
Published: (2022-05-01) -
The Interaction of CD97/ADGRE5 With β-Catenin in Adherens Junctions Is Lost During Colorectal Carcinogenesis
by: Doris Hilbig, et al.
Published: (2018-05-01) -
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
by: Candace J. Poole, et al.
Published: (2018-11-01) -
Comprehensive analysis of ADGRE5 gene in human tumors: Clinical relevance, prognostic implications, and potential for personalized immunotherapy
by: Xiangjian Zhang, et al.
Published: (2024-03-01) -
DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations.
by: Chidimma Agatha Akpa, et al.
Published: (2019-01-01)